EquityFlow › Companies › PerioTrap

PerioTrap

Biotech · Halle, DE

Nuovo approccio terapeutico contro la parodontite con principio attivo selettivo.

Funding history

DateRoundAmount
Mar 2026Funding round
PerioTrap raises 2.9 million euros from the Companisto network and bmp Ventures.
$3.4M

Investors

Companistobmp Ventures

Similar companies in Biotech

ImperagenHaga BiosciencePixelgen TechnologiesGallantChai DiscoverySNIPR BiomeCellbox LabsScope BiosciencesGenLuminaActitheraNUCLIDIUMAnocca
Explore funding flow on EquityFlow →